Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


In Brief

This article was originally published in The Tan Sheet

Executive Summary

Nestle takes stake in constipation cure firm

Nestle takes stake in constipation cure firm

Nestle Health Science acquires a minority stake in New Zealand nutritional firm Vital Foods, which markets kiwifruit extract constipation cures Kiwi Crush and Phloe. The deal, announced July 14, gives Nestle a seat on Vital Foods’ board of directors. Other terms were not disclosed. "Their products align strongly with Nestle Health Science’s commitment to science-based nutritional solutions for gastrointestinal health," Nestle Health Science President and CEO Luis Cantarell said in a release. The Swiss firm previously acquired clinical nutrition maker Vitaflo and gastrointestinal diagnostics maker Prometheus Laboratories (Also see "Nestle Health Science Plans Continuum Of Care" - Pink Sheet, 4 Jul, 2011.).

Mag-Ox sales boost Hi-Tech OTC unit

Sales in Hi-Tech Pharmacal's Health Care Products division grew 24% to $3.3 million in the fourth quarter and 23% to $13.9 million in fiscal 2011, as the firm reported growth of the Mag-Ox magnesium supplement line acquired in March 2010. The Amityville, N.Y., firm increased net sales 45.3% to $57.2 million in the quarter ended April 30 and 19.8% to $190.9 million for the year, partly due to strong sales of Rx fluticasone propionate nasal spray, a generic of GlaxoSmithKline's Flonase. Hi-Tech said July 7 net income nearly doubled to $12.7 million in the fourth quarter and jumped 33.2% to $41.5 million in 2011.

Schiff, Aker BioMarine expand deal

Aker BioMarine will deliver up to 300 metric tons of krill oil per year to Schiff Nutrition International under an expanded supply deal announced July 6. Schiff gains certain exclusive sales rights and the firms agree to collaborate on future innovations, they said in a release. The agreement goes through at least June 2016 and "secures a sustainable source capable of meeting our growth aspirations," Schiff CEO Tarang Amin said.

Divine Skin expands to supplements

The biotech developer signs an exclusive deal with supplement maker NutraOrigin to market 63 supplements, the firms announce July 12. Divine Skin will receive 30% of all revenue from global sales. Divine Skin touted NutraOrigin’s omega-3 fatty acid formula, which “improved reaction time and accuracy and reduced drowsiness and anxiety” among participants in a clinical trial. It also touted a recent deal to launch NutraOrigin at Whole Foods.

Flaxseed claims take flak from FDA

Premium Gold Flax Products & Processing Inc. made unapproved drug claims for its flaxseed products, FDA says in a July 1 warning letter. The Denhoff, N.D., company's websites said the lignans in flaxseed are "natural cancer-preventative phytonutrients" that may prevent breast cancer as well as type 2 diabetes, according to the agency's Minneapolis district office. Other violative claims cited in the letter said flaxseed can reduce inflammation and lower cholesterol.

Muscle Milk labeling draws warning

FDA finds the Muscle Milk nutritional shakes improperly use "milk" wording on their labels. For one, the CytoSport products are misbranded as milk despite containing no milk, a June 29 warning letter says. Conversely, the "Contains No Milk" statement on Muscle Milk labels could give consumers a false impression that the shakes are free of milk-derived ingredients, despite containing milk protein isolate and whey, according to FDA's San Francisco district office. Benicia, Calif.-based CytoSport also misbranded its Muscle Milk products with unauthorized nutrient content claims, FDA says.

FDA warns supplements have sibutramine

The agency advises consumers not to purchase or use various weight-loss products marketed by InterCharm because they contain the now-withdrawn Rx ingredient sibutramine. The products were sold online under the names Slim Forte Slimming Capsules, Slim Forte Slimming Coffee and Botanical Slimming Soft Gel. Sibutramine can increase blood pressure and may interact in life-threatening ways with other medication, the agency adds in a July 8 release.

MHRA warns about tainted ED products

The U.K.'s Medicines and Healthcare products Regulatory Agency warns consumers June 27 not to use Africa Black Ant, Rock Hard Weekend, Pandora and The Best because they include the undeclared prescription drug sildenafil. The products are promoted as "herbal Viagra" and "sexual enhancers," and FDA and the Federal Agency for Medicinal and Health Products in Belgium found them adulterated, according to MHRA.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts